Last Participant Enrolled in Study of Infant Microbiome and Immune Health
/PRNewswire/ -- Infinant Health, Inc, a company focused on improving infant health through the gut microbiome, today announced the enrollment of the final...
Stay updated with breaking news from Text View. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Infinant Health, Inc, a company focused on improving infant health through the gut microbiome, today announced the enrollment of the final...
/PRNewswire/ -- Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today the commercial launch and dosing of...
/PRNewswire/ -- Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced today the first production batch has been...
- FDA approval of Elucirem™ (NDA 216986) was granted after priority review, a designation assigned to applications for drugs that provide significant...
- FDA approval of Elucirem™ (NDA 216986) was granted after priority review, a designation assigned to applications for drugs that provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions compared to available therapies. - In the approved indications, a contrast-enhanced MRI exa...